IDH2 and chondrosarcoma: Here we report metabolic differences between mutant IDH chondrosarcomas and non-mutant chondrosarcomas across a spectrum of organic acids, amino acids, and acylcarnitines measured by targeted GC/MS and MS/MS mass spectrometry.